London Daily

Focus on the big picture.
Monday, Aug 04, 2025

Cannabis pioneer says sector must shake off its ‘hocus pocus’ image to thrive

Cannabis pioneer says sector must shake off its ‘hocus pocus’ image to thrive

The founder of London’s first listed medicinal cannabis firm said the sector must shake off its “hocus-pocus” image before companies can fulfil their clinical and commercial potential.

Roby Zomer, CEO of MGC Pharma — which floated on the London Stock Exchange’s main market in February — said: “There needs to be a shift within the industry for doctors to see cannabis as a medicine and not just a lifestyle product.”

Although medical cannabis was legalised for conditions such as epilepsy and multiple sclerosis in 2018, vanishingly few NHS prescriptions have been handed out.

This reluctance is among factors blamed for cool investor enthusiasm for plant-derived medicines compared to superstar cousins in life sciences and biotech, despite forecasts valuing the cannabis market at $57 billion by 2027 in the US alone.

Roby Zomer, CEO of MGC Pharma


Zomer said: “We need time, we are still only at the beginning. We’re a small company, and undervalued - but to me, we’re in the same league as Pfizer.”

He spoke as MGC’s Covid-19 drug CimetrA — an oral spray derived from turmeric — was granted an emergency import licence to begin trials in pandemic-ravaged India.

The drug targets receptors to dampen the immune system’s overreaction to the virus, muzzling ‘cytokine storms’ that can trigger organ failure and lead to death.

Final stage tests are ongoing in Israel, and the company is also in discussions with agencies in the EU and US and the World Health Organisation.

MGC Pharma


MGC’s shares rose 5.5% to 3.08p as details of the new trials were announced, still well below Canaccord Genuity’s latest 8p “speculative buy” price target which would lift its market value above £100million.

Since launching in 2015, MGC Pharma has evolved from a nutrition and cosmetics brand into clinical therapy, and now employs around 50 scientists at its research centre in Slovenia.

Their attention switched to Covid-19 when the pandemic hit in March last year.

Zomer, 40, has every reason to believe in CimetrA’s effectiveness: he and his wife took the drug after testing positive for Covid on their return from visiting family in Russia in January.

“When the plane landed in Israel I did the test and was positive. We all got it together, it hit me hard,” he said. “I wasn’t able almost to breathe or speak or walk up the stairs for two weeks.

“We both took CimetrA and within 48 hours my wife was able to function. It took me a little longer, but in one week I was like a new person. So yes, I totally believe it works.

“The Pfizer CEO didn’t try his vaccine on himself before it got FDA approval!” he added.

If marketing approval is granted for emergency use in India, after a 90-day review process which is being overseen by Medopharm, the firm intends to apply for a licence to sell CimetrA over the counter.

MGC Pharma


A course costs around $100, a fraction of the cost of existing synthetic treatments.

Zomer said: “In the end we need to learn to live with Covid. The vaccine is reducing the spread but, as we’re seeing in Israel, it’s not preventing it.

”We need safe, affordable, easy-to-administer treatments that suppress the symptoms and prevent hospitalisation and death.”

MGC has factories in Germany and the US on standby to scale up for the production of millions of doses as it constructs a dedicated facility in Malta.

In June, MGC’s epilepsy treatment CannEpil became the first pharmaceutical-grade cannabis product to be approved for prescription free of charge under Ireland’s health insurance scheme.

Zomer said: “I’m very excited, it’s a thrilling time to have grown MGC from an idea to become players in the main league of pharmaceuticals companies.

“We see the effort we invested into science maturing into real breakthrough medicine in less than 18 months.”

Newsletter

Related Articles

0:00
0:00
Close
UK's Online Safety Law: A Front for Censorship
Nationwide Protests Erupt in Brazil Demanding Presidential Resignation
Parents Abandon Child at Barcelona Airport Over Passport Issue
Mystery Surrounds Death of Brazilian Woman with iPhones Glued to Her Body
Bus Driver Discovers Toddler Hidden in Suitcase in New Zealand
Switzerland Celebrates 734 Years of Independence Amid Global Changes
U.S. Opens Official Investigation into Former Trump Prosecutor Jack Smith
Leaked audio of Canada's new PM Mark Carney admitting the truth about the Net Zero agenda: "We're gonna make a lot of money off of this."
China Enforces Comprehensive Ban on Cryptocurrency Activities
Absolutely 100% Realistic EVO Series Doll by EXDOLL (Chinese Company) used mainly for carnal purposes
World Economic Forum founder Klaus Schwab: "In this new world, we must accept... total transparency. You have to get used to it. You have to behave accordingly. But if you have nothing to hide, you shouldn't be afraid."
Meet Mufti Hamid Patel, head of Office for Standards in Education in Pakistan
George Soros tells the World Economic Forum: "President Trump is a con man and the ultimate narcissist, who wants the world to revolve around him."
Hamas are STARVING the hostages.
Decline in Tourism in Majorca Amidst Ongoing Anti-Tourism Protests
British Tourist Dies Following Hair Transplant in Turkey, Police Investigate
Poland Begins Excavation at Dziemiany After New Clue to World War II‑Era Nazi Treasure
WhatsApp Users Targeted in New Scam Involving Account Takeovers
Trump Threatens Canada with Tariffs Over Palestinian State Recognition
Trump Deploys Nuclear Submarines After Threats from Former Russian President Medvedev
Trump Sues Murdoch in “Heavyweight Bout”: Lawsuit Over Alleged Epstein Letter Sets Stage for Courtroom Showdown
Germany Enters Fiscal Crisis as Cabinet Approves €174 Billion in New Debt
Trump Administration Finalizes Broad Tariff Increases on Global Trade Partners
J.K. Rowling Limits Public Engagements Citing Safety Fears
JD.com Launches €2.2 Billion Bid for German Electronics Retailer Ceconomy
Azerbaijan Proceeds with Plan to Legalise Casinos on Artificial Islands
Former Judge Charged After Drunk Driving Crash Kills Comedian in Brazil
Jeff Bezos hasn’t paid a dollar in taxes for decades. He makes billions and pays $0 in taxes, LEGALLY
China Increases Use of Exit Bans Amid Rising U.S. Tensions
IMF Upgrades Global Growth Forecast as Weaker Dollar Supports Outlook
Procter & Gamble to Raise U.S. Prices to Offset One‑Billion‑Dollar Tariff Cost
House Republicans Move to Defund OECD Over Global Tax Dispute
Botswana Seeks Controlling Stake in De Beers as Anglo American Prepares Exit
Trump Administration Proposes Repeal of Obama‑Era Endangerment Finding, Dismantling Regulatory Basis for CO₂ Emissions Limits
France Opens Criminal Investigation into X Over Algorithm Manipulation Allegations
A family has been arrested in the UK for displaying the British flag
Mel Gibson refuses to work with Robert De Niro, saying, "Keep that woke clown away from me."
Trump Steamrolls EU in Landmark Trade Win: US–EU Trade Deal Imposes 15% Tariff on European Imports
ChatGPT CEO Sam Altman says people share personal info with ChatGPT but don’t know chats can be used as court evidence in legal cases.
The British propaganda channel BBC News lies again.
Deputy attorney general's second day of meeting with Ghislaine Maxwell has concluded
Controversial March in Switzerland Features Men Dressed in Nazi Uniforms
Politics is a good business: Barack Obama’s Reported Net Worth Growth, 1990–2025
Thai Civilian Death Toll Rises to 12 in Cambodian Cross-Border Attacks
TSUNAMI: Trump Just Crossed the Rubicon—And There’s No Turning Back
Over 120 Criminal Cases Dismissed in Boston Amid Public Defender Shortage
UN's Top Court Declares Environmental Protection a Legal Obligation Under International Law
"Crazy Thing": OpenAI's Sam Altman Warns Of AI Voice Fraud Crisis In Banking
The Podcaster Who Accidentally Revealed He Earns Over $10 Million a Year
Trump Announces $550 Billion Japanese Investment and New Trade Agreements with Indonesia and the Philippines
×